TriVerity
Provider 
Founded 2016
Sells To B2B, Enterprise
Pricing Model Product Sales, Recurring, Software
Ownership Venture-backed

Rapid host-response blood test reporting bacterial and viral infection likelihood plus seven-day severity risk for emergency patients.
The TriVerity Test System pairs a single-use cartridge with the Myrna instrument to measure 29 immune-response genes and compute bacterial, viral, and severity scores in about 30 minutes for adults with suspected acute infection or sepsis.
Emergency teams use the scores to guide antibiotic, testing, and admission choices, supported by SEPSIS-SHIELD validation across 1,222 patients at 22 sites and FDA marketing clearance in January 2025.
Lumos Diagnostics

FebriDx
lumosdiagnostics.com
Cytovale

IntelliSep
cytovale.com
MeMed

MeMed
me-med.com
Immunexpress

SeptiCyte RAPID
immunexpress.com
Adds products that compete with one of TriVerity’s direct competitors but not with TriVerity itself. They are shaded, and Linked Through names the direct competitor each one competes with.
| Attribute | TriVerity | FebriDx | IntelliSep | MeMed | SeptiCyte RAPID | |
|---|---|---|---|---|---|---|
| Provider | ||||||
| Founded | 2016 | — | 2013 | 2009 | — | |
| Sells To | B2B, Enterprise | — | Enterprise, Government | B2B | — | |
| Pricing Model | Product Sales, Recurring, Software | — | Recurring, Software | Product Sales, Subscription | — | |
| Ownership | Venture-backed | — | Venture-backed | — | — |
Provider 
Founded 2016
Sells To B2B, Enterprise
Pricing Model Product Sales, Recurring, Software
Ownership Venture-backed
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —
Provider 
Founded 2013
Sells To Enterprise, Government
Pricing Model Recurring, Software
Ownership Venture-backed
Provider 
Founded 2009
Sells To B2B
Pricing Model Product Sales, Subscription
Ownership —
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —